clarithromycin has been researched along with Infections, Respiratory Syncytial Virus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bivan, S; Govindarajan, S | 1 |
| Chang, AB; McCallum, GB; Morris, PS; Plumb, EJ | 1 |
| Himi, T; Kakuki, T; Kamekura, R; Kojima, T; Miyata, R; Ogasawara, N; Sato, T; Shiraishi, T; Takano, K; Tsutsumi, H; Yamamoto, K; Yamamoto, S; Yokota, SI | 1 |
| Fujii, N; Himi, T; Hirakawa, S; Okabayashi, T; Tsutsumi, H; Yokota, S | 1 |
| Chang, AB; McCallum, GB; Morris, PS | 1 |
| Koc, N; Ozcan, A; Tahan, F | 1 |
| Kimpen, JL; Kneyber, MC | 1 |
2 review(s) available for clarithromycin and Infections, Respiratory Syncytial Virus
| Article | Year |
|---|---|
Antibiotics for persistent cough or wheeze following acute bronchiolitis in children.
Topics: Acute Disease; Anti-Bacterial Agents; Bronchiolitis; Clarithromycin; Cough; Humans; Infant; Randomized Controlled Trials as Topic; Respiratory Sounds; Respiratory Syncytial Virus Infections | 2017 |
Antibiotics for persistent cough or wheeze following acute bronchiolitis in children.
Topics: Acute Disease; Anti-Bacterial Agents; Bronchiolitis; Clarithromycin; Cough; Humans; Infant; Randomized Controlled Trials as Topic; Respiratory Sounds; Respiratory Syncytial Virus Infections | 2012 |
1 trial(s) available for clarithromycin and Infections, Respiratory Syncytial Virus
| Article | Year |
|---|---|
Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial.
Topics: Anti-Bacterial Agents; Bronchiolitis, Viral; Chemokine CCL11; Chemokines, CC; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infant; Interferon-gamma; Interleukin-4; Interleukin-8; Length of Stay; Male; Respiratory Syncytial Virus Infections | 2007 |
4 other study(ies) available for clarithromycin and Infections, Respiratory Syncytial Virus
| Article | Year |
|---|---|
Viral and bacterial coinfection of the respiratory tract in a 10-month-old child.
Topics: Adenoviridae Infections; Anti-Bacterial Agents; Bordetella Infections; Clarithromycin; Coinfection; Female; Fluid Therapy; Hospitalization; Humans; Infant; Multiplex Polymerase Chain Reaction; Nasopharynx; Oxygen Inhalation Therapy; Radiography; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Treatment Outcome | 2020 |
Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3.
Topics: A549 Cells; Active Transport, Cell Nucleus; Clarithromycin; Epithelial Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Immunologic Factors; Inflammation Mediators; Interferon Regulatory Factor-3; Interferons; Lung; Protein Multimerization; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Signal Transduction; Toll-Like Receptor 3; Transfection | 2016 |
Clarithromycin suppresses human respiratory syncytial virus infection-induced Streptococcus pneumoniae adhesion and cytokine production in a pulmonary epithelial cell line.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Clarithromycin; Cytokines; Epithelial Cells; Humans; Lung; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Streptococcus pneumoniae | 2012 |
Antibiotics in RSV bronchiolitis: still no evidence of effect.
Topics: Anti-Bacterial Agents; Bronchiolitis, Viral; Chemokine CCL11; Chemokines, CC; Clarithromycin; Drug Administration Schedule; Humans; Infant; Randomized Controlled Trials as Topic; Recurrence; Research Design; Respiratory Syncytial Virus Infections; Time Factors | 2007 |